AlphaStar Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-445
| Closed | -$207K | – | 380 |
|
|
2024
Q3 | $207K | Sell |
445
-76
| -15% | -$35.3K | 0.02% | 355 |
|
|
2024
Q2 | $244K | Sell |
521
-100
| -16% | -$46.9K | 0.02% | 280 |
|
|
2024
Q1 | $260K | Sell |
621
-178
| -22% | -$74.4K | 0.03% | 250 |
|
|
2023
Q4 | $325K | Sell |
799
-837
| -51% | -$341K | 0.03% | 223 |
|
|
2023
Q3 | $569K | Buy |
+1,636
| New | +$569K | 0.07% | 164 |
|
|
2022
Q2 | – | Sell |
-5,964
| Closed | -$1.56M | – | 403 |
|
|
2022
Q1 | $1.56M | Buy |
5,964
+300
| +5% | +$78.3K | 0.13% | 127 |
|
|
2021
Q4 | $1.33M | Buy |
+5,664
| New | +$1.33M | 0.11% | 147 |
|